Sedana Medical AB (publ)
STO:SEDANA

Watchlist Manager
Sedana Medical AB (publ) Logo
Sedana Medical AB (publ)
STO:SEDANA
Watchlist
Price: 12.38 SEK 4.74% Market Closed
Market Cap: 1.2B SEK
Have any thoughts about
Sedana Medical AB (publ)?
Write Note

Sedana Medical AB (publ)
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sedana Medical AB (publ)
Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
Sedana Medical AB (publ)
STO:SEDANA
Cash
kr226.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Cash
kr666.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Cash
kr137.7m
CAGR 3-Years
7%
CAGR 5-Years
-9%
CAGR 10-Years
9%
Getinge AB
STO:GETI B
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Cash
kr923m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sedana Medical AB (publ)
Glance View

Market Cap
1.2B SEK
Industry
Health Care

Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.

SEDANA Intrinsic Value
7.85 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Sedana Medical AB (publ)'s Cash?
Cash
226.4m SEK

Based on the financial report for Sep 30, 2024, Sedana Medical AB (publ)'s Cash amounts to 226.4m SEK.

What is Sedana Medical AB (publ)'s Cash growth rate?
Cash CAGR 1Y
-22%

Over the last year, the Cash growth was -22%.

Back to Top